Drugs

, Volume 35, Supplement 7, pp 35–38 | Cite as

Sulbactam/Ampicillin in Paediatric Infections

  • Adnan S. Dajani
Section 3: Clinical Profiles of Sulbactam/Ampicillin

Summary

The emergence and spread of ampicillin- resisiant Haemophilus influenzae type b strains have led to a sharp reduction in the use of ampicillin, or the addition of chloramphenicol, in the initial therapy of serious childhood infections. In some instances, third generation cephalosporins are used instead.

The combination of ampicillin with sulbactam restores the former usefulness of ampicillin and extends its spectrum of activity to include normally ampicillin- resistant Staphylococcus aureus. Sulbactam/ampicillin should be useful in treating bacterial meningitis. It is more effective than third generation cephalosporins against Listeria and enterococci, and is more effective than ampicillin against Enterobacteriaceae. The combination also holds promise as a treatment for soft tissue, bone and joint infections in children.

Keywords

Meningitis Ampicillin Chloramphenicol Cefotaxime Listeria 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aronoff SC, Scoles PV, Makley JT, Jacobs MR, Blumer JL, et al. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children. Reviews of Infectious Diseases 8 (Suppl.): S639–S643, 1986PubMedCrossRefGoogle Scholar
  2. Chang MJ. Escobedo M, Anderson DC, Hillman L, Feigin RD. Kanamycin and gentamicin treatment of neonatal sepsis and meningitis. Pediatrics 56: 695–699, 1975PubMedGoogle Scholar
  3. Foster MC, Kapila L, Morns DL, Slack RCB. A randomized comparative study of sulbactam plus ampicillin vs metronidazole plus cefotaxime in the treatment of acute appendicitis in children. Reviews of Infectious Diseases 8 (Suppl.): S634–S638, 1986Google Scholar
  4. McCracken GH, Mize SG, Threlkeld N. Intraventricular gentamicin therapy in Gram-negative bacillary meningitis of infancy. Report of the second neonatal meningitis cooperative study group. Lancet 1: 787–791, 1980PubMedGoogle Scholar
  5. Rodriguez WJ, Khan WN, Puig J, Feris J, Harmon S, et al. Sulbactam/ampicillin vs chloramphenicol/ampicillin for the treatment of meningitis in infants and children. Reviews of Infectious Diseases 8 (Suppl.): S620–S629, 1986PubMedCrossRefGoogle Scholar
  6. Syriopoulou V, Bitsi M. Theodoridis C, Saroglou I, Krikos X, et al. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms. Reviews of Infectious Diseases 8 (Suppl): S630–S633, 1986PubMedCrossRefGoogle Scholar
  7. Wald E, Reilly JS, Bluestone CD, Chiponis D. Sulbactam/ampicillin in the treatment of acute epiglottitis in children. Reviews of Infectious Diseases 8 (Suppl.): S617–S619, 1986PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • Adnan S. Dajani
    • 1
  1. 1.Division of Infectious Diseases, Children’s Hospital of MichicganWayne State University, DirectorDetroitUSA

Personalised recommendations